Donga Socio Holdings Cash Flow Conversion Efficiency
Donga Socio Holdings cash flow conversion efficiency. Based on the latest financial reports, Donga Socio Holdings (000640) has a cash flow conversion efficiency ratio of 0.064x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩71.18 Billion ≈ $48.23 Million USD) by net assets (₩1.11 Trillion ≈ $754.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Donga Socio Holdings (2000–2024)
Cash flow conversion efficiency of Donga Socio Holdings from 2000 to 2024. This chart illustrates how Donga Socio Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Donga Socio Holdings for real-time trading data and today's change.
Donga Socio Holdings Cash Flow Conversion Ratio Explained
Donga Socio Holdings cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Donga Socio Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Donga Socio Holdings ranked by their cash flow conversion efficiency. Also see Donga Socio Holdings stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tibet Tourism Co Ltd
SHG:600749
|
0.052x |
|
Frontera Energy Corp
TO:FEC
|
-0.019x |
|
Yingde Greatchem Chemicals Co. Ltd. A
SHE:300804
|
N/A |
|
Trusval Technology Co Ltd
TWO:6667
|
-0.055x |
|
Hangzhou Wensli Silk Culture Co. Ltd.
SHE:301066
|
N/A |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
0.013x |
|
Qijing Machinery
SHG:603677
|
0.056x |
|
Lendingtree Inc
NASDAQ:TREE
|
0.091x |
Annual Cash Flow Conversion Efficiency for Donga Socio Holdings (2000–2024)
The table below shows the annual cash flow conversion efficiency of Donga Socio Holdings from 2000 to 2024. Review 000640 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.06 Trillion ≈ $721.02 Million |
₩82.99 Billion ≈ $56.24 Million |
0.078x | -49.50% |
| 2023-12-31 | ₩1.03 Trillion ≈ $696.19 Million |
₩158.70 Billion ≈ $107.55 Million |
0.154x | +103.33% |
| 2022-12-31 | ₩998.66 Billion ≈ $676.78 Million |
₩75.87 Billion ≈ $51.42 Million |
0.076x | -42.91% |
| 2021-12-31 | ₩985.04 Billion ≈ $667.55 Million |
₩131.09 Billion ≈ $88.84 Million |
0.133x | +39.84% |
| 2020-12-31 | ₩888.72 Billion ≈ $602.28 Million |
₩84.57 Billion ≈ $57.31 Million |
0.095x | -26.56% |
| 2019-12-31 | ₩746.90 Billion ≈ $506.17 Million |
₩96.79 Billion ≈ $65.59 Million |
0.130x | +63.48% |
| 2018-12-31 | ₩735.76 Billion ≈ $498.62 Million |
₩58.32 Billion ≈ $39.52 Million |
0.079x | -14.19% |
| 2017-12-31 | ₩914.25 Billion ≈ $619.57 Million |
₩84.46 Billion ≈ $57.23 Million |
0.092x | +165.49% |
| 2016-12-31 | ₩875.86 Billion ≈ $593.56 Million |
₩30.48 Billion ≈ $20.65 Million |
0.035x | -74.09% |
| 2015-12-31 | ₩602.64 Billion ≈ $408.40 Million |
₩80.94 Billion ≈ $54.85 Million |
0.134x | +1006.86% |
| 2014-12-31 | ₩534.48 Billion ≈ $362.21 Million |
₩-7.92 Billion ≈ $-5.36 Million |
-0.015x | -121.30% |
| 2013-12-31 | ₩514.60 Billion ≈ $348.74 Million |
₩35.78 Billion ≈ $24.25 Million |
0.070x | +9.96% |
| 2012-12-31 | ₩881.24 Billion ≈ $597.20 Million |
₩55.72 Billion ≈ $37.76 Million |
0.063x | -55.12% |
| 2011-12-31 | ₩862.39 Billion ≈ $584.43 Million |
₩121.50 Billion ≈ $82.34 Million |
0.141x | -27.35% |
| 2010-12-31 | ₩745.61 Billion ≈ $505.29 Million |
₩144.60 Billion ≈ $97.99 Million |
0.194x | +16.36% |
| 2009-12-31 | ₩580.35 Billion ≈ $393.29 Million |
₩96.72 Billion ≈ $65.55 Million |
0.167x | -7.93% |
| 2008-12-31 | ₩350.94 Billion ≈ $237.83 Million |
₩63.53 Billion ≈ $43.05 Million |
0.181x | +33.72% |
| 2007-12-31 | ₩328.69 Billion ≈ $222.75 Million |
₩44.50 Billion ≈ $30.15 Million |
0.135x | -48.05% |
| 2006-12-31 | ₩319.55 Billion ≈ $216.55 Million |
₩83.27 Billion ≈ $56.43 Million |
0.261x | +150.16% |
| 2005-12-31 | ₩344.22 Billion ≈ $233.27 Million |
₩35.86 Billion ≈ $24.30 Million |
0.104x | -32.88% |
| 2004-12-31 | ₩306.84 Billion ≈ $207.94 Million |
₩47.62 Billion ≈ $32.27 Million |
0.155x | -12.46% |
| 2003-12-31 | ₩266.72 Billion ≈ $180.76 Million |
₩47.29 Billion ≈ $32.05 Million |
0.177x | -19.32% |
| 2002-12-31 | ₩219.52 Billion ≈ $148.77 Million |
₩48.24 Billion ≈ $32.69 Million |
0.220x | -28.61% |
| 2001-12-31 | ₩190.87 Billion ≈ $129.35 Million |
₩58.75 Billion ≈ $39.81 Million |
0.308x | +44.13% |
| 2000-12-31 | ₩208.05 Billion ≈ $141.00 Million |
₩44.43 Billion ≈ $30.11 Million |
0.214x | -- |
About Donga Socio Holdings
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more